Tucson biotech firm HTG Molecular files for bankruptcy
Tucson-based biotech firm HTG Molecular Diagnostics has filed for Chapter 11 bankruptcy, with plans to operate as it works out a plan to pay its debts.
Source: tucson.com
Stay updated with breaking news from Selectide Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tucson-based biotech firm HTG Molecular Diagnostics has filed for Chapter 11 bankruptcy, with plans to operate as it works out a plan to pay its debts.